The Food and Drug Administration is weighing whether to follow British regulators in resuming a coronavirus vaccine trial that was halted when a participant suffered spinal cord damage, even as the National Institutes of Health has launched an investigation of the case.
from CNN.com - RSS Channel - HP Hero https://www.cnn.com/2020/09/15/health/covid-19-vaccine-trial-astrazeneca-nih-fda-kaiser/index.html
via https://www.cnn.com/index.html
No comments:
Post a Comment